NL-OMON35738
Completed
Not Applicable
Role of flow cytometry in the assessment of restoration of hematopoiesis during standard Exjade® treatment in patients with low- intermediate I risk myelodysplastisc syndromes, a pilot study - NVT
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- n.a.
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •MDS type low and intermediate risk, supportive care treatment, start Exjade®
Exclusion Criteria
- •Comorbidity, anaemia MDS unrelated, previous treatment with Exjade®
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
sing tissue samples to help diagnose and predict the outcome of blood cancer using a machine that analyzes cell charecteristicsCTRI/2023/09/058112Dr Abhishek Tiwari
Completed
Not Applicable
Investigation of clinical utility of flow cytometry using endoscopically biopsied specimen for diagnosis of gastrointestinal lymphomaJPRN-UMIN000027730Okayama University Hospital200
Completed
Not Applicable
Interest of Flow Cytometry for the Diagnosis, the Follow up and Specific Immunotherapy (SIT) Arrest of Hymenoptera Venom AllergyAllergyNCT00805402University Hospital, Limoges75
Not yet recruiting
Not Applicable
Role of flow cytometric immunophenotyping in staging of pediatric solid round cell tumorsCTRI/2017/02/007944Tata Memorial Hospital60
Recruiting
Not Applicable
Assessments of the new cutoff value and the accuracy of Intraoperative flow cytometer for the intraoperative frozen section diagnosis and the intraoperative frozen section diagnosis of the resection margin in malignant brain tumor surgeryMalignant Brain TumorJPRN-UMIN000049170Hirosaki University Graduate School of Medicine100